Status:
RECRUITING
Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
Lead Sponsor:
McGill University
Collaborating Sponsors:
Genome Canada
Genome Quebec
Conditions:
Diagnoses Disease
Eligibility:
FEMALE
45-75 years
Phase:
NA
Brief Summary
Early stage high-grade cancer, endometrial and ovarian, has few, if any, symptoms or signs. When symptoms appear, the disease is commonly in advanced stage meaning it has left the gynaecological organ...
Eligibility Criteria
Inclusion
- \- Capacity to understand study and provide informed consent
Exclusion
- Prior hysterectomy
- Be pregnant
- Be nursing
- Be undergoing any fertility treatment
- Have had recent history of uterine perforation
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2028
Estimated Enrollment :
5600 Patients enrolled
Trial Details
Trial ID
NCT04891029
Start Date
May 10 2021
End Date
November 1 2028
Last Update
June 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill University Health Centre, Royal Victoria Hospital
Montreal, Quebec, Canada, H4A 3J1
2
Queen Elizabeth Health Complex
Montreal, Quebec, Canada, H4A 3K6